Literature DB >> 24953203

Development and validation of the Mayo Clinic Bowel Prep Tolerability Questionnaire.

Mihir Patel1, Estela Staggs2, Colleen S Thomas3, Frank Lukens1, Michael Wallace1, Cristina Almansa4.   

Abstract

BACKGROUND: Bowel cleansing is paramount for colonoscopy quality. Unfortunately, an adequate bowel preparation is often limited by side effects and/or patient's intolerance to bowel preparation solutions. Comparisons among different preparations are limited by the lack of validated instruments designed to assess patient's tolerability. AIM: To develop and validate a simple, comprehensive instrument to assess bowel preparation tolerability in patients undergoing colonoscopy.
METHODS: Development and validation by phases: Phase I (bibliographic search and questionnaire design); Phase II (assessment of content validity and modification of the questionnaire); Phase III (assessment of reproducibility, final validation, and definitive version of the questionnaire).
RESULTS: The initial draft of the questionnaire was generated based on a systematic literature review and feedback from a panel of consultants. Content validity was tested in a focus group of 25 patients undergoing colonoscopy. Patients' suggestions were reviewed by the research team and a second draft of the questionnaire was generated. Final validation and reproducibility were successfully tested (agreement: 86-100%, kappa: 0.77-1.00) in a convenience sample of 100 patients undergoing bowel preparation with different cleansing solutions.
CONCLUSION: The Mayo Clinic Bowel Prep Tolerability Questionnaire is a simple, comprehensive instrument suitable to evaluate the tolerability of various types of bowel preparations.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bowel preparation; Colonoscopy; Questionnaire; Tolerability

Mesh:

Substances:

Year:  2014        PMID: 24953203     DOI: 10.1016/j.dld.2014.05.020

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  11 in total

1.  Sensory characterization of bowel cleansing solutions.

Authors:  Ala I Sharara; Hamza Daroub; Camille Georges; Rani Shayto; Ralph Nader; Jean Chalhoub; Ammar Olabi
Journal:  World J Gastrointest Endosc       Date:  2016-08-10

2.  The burden of bowel preparations in patients undergoing elective colonoscopy.

Authors:  Ala I Sharara; Zeinab D El Reda; Ali H Harb; Carla G Abou Fadel; Fayez S Sarkis; Jean M Chalhoub; Rachel Abou Mrad
Journal:  United European Gastroenterol J       Date:  2015-07-03       Impact factor: 4.623

3.  Can a 1-day clear liquid diet with a split -dose polyethylene glycol overcome conventional practice patterns during the preparation for screening colonoscopy?

Authors:  Diğdem Özer Etik; Nuretdin Suna; Cemre Gündüz; Ahmet Bostan; Alperen Özdemir; Bade Yağmur Gürel; Ezgi Yenişekerci; Ahmet Sedat Boyacıoğlu
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

4.  Validation of a Patient Satisfaction Scale in Patients Undergoing Bowel Preparation Prior to Colonoscopy.

Authors:  Hind T Hatoum; Swu-Jane Lin; Raymond E Joseph; David N Dahdal
Journal:  Patient       Date:  2016-02       Impact factor: 3.883

5.  Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trial.

Authors:  Lawrence Hookey; Gerald Bertiger; Kenneth Lee Johnson; Julia Ayala; Yodit Seifu; Stuart P Brogadir
Journal:  Therap Adv Gastroenterol       Date:  2019-05-19       Impact factor: 4.409

6.  Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study.

Authors:  Lawrence Hookey; Gerald Bertiger; Kenneth Lee Johnson; Mena Boules; Masakazu Ando; David N Dahdal
Journal:  Therap Adv Gastroenterol       Date:  2020-04-09       Impact factor: 4.409

7.  A Phase 2 Randomized Trial of DCL-101, a Novel Pill-Based Colonoscopy Prep, vs 4L Polyethylene Glycol-Electrolyte Solution.

Authors:  Dale R Bachwich; James D Lewis; Vera O Kowal; Brian C Jacobson; Audrey H Calderwood; Michael L Kochman
Journal:  Clin Transl Gastroenterol       Date:  2020-12       Impact factor: 4.396

8.  Safety and efficacy of sodium picosulfate, magnesium oxide, and citric acid bowel preparation in patients with baseline renal impairment or diabetes: subanalysis of a randomized, controlled trial.

Authors:  Gautam N Mankaney; Masakazu Ando; David N Dahdal; Carol A Burke
Journal:  Therap Adv Gastroenterol       Date:  2021-06-28       Impact factor: 4.409

9.  Split- versus single-dose preparation tolerability in a multiethnic population: decreased side effects but greater social barriers.

Authors:  Gabriel Perreault; Adam Goodman; Sebastian Larion; Ahana Sen; Kirsten Quiles; Michael Poles; Renee Williams
Journal:  Ann Gastroenterol       Date:  2018-03-28

10.  Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded study.

Authors:  Lawrence Hookey; Gerald Bertiger; Kenneth Lee Johnson; Mena Boules; Masakazu Ando; David N Dahdal
Journal:  Therap Adv Gastroenterol       Date:  2020-02-07       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.